China is a manufacturing superpower and in many industries U.S. companies have a hard time competing. Now, many policy makers are interested in boosting manufacturing of medical products and drugs in the U.S.
Matt speaks with Beth Schenk, executive director of environmental stewardship for Providence, a health system that has a network of more than 50 hospitals in the Western U.S. Matt and Beth discuss the carbon footprint of the health care supply chain and how health care providers, distributors and...
Most of the drugs sold in the U.S. come from overseas, exposing those supply chains to disruptions like natural disasters or political conflicts. Some researchers argue that using 3D printing to make drugs at the site of care could increase resiliency.
The demand for gloves soared during the COVID-19 pandemic and those issues still persist. Now, a nationwide lockdown in Malaysia, which produces most of the world’s gloves, is slowing down production. The lockdown could last for weeks.